Company: CRL
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001100682-25-000011
Chunk: 160

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 160
---
 this information is not separately identified and internally reported to the Company’s CODM. The following table presents the results of operations by reportable segment:Fiscal YearDecember 28, 2024December 30, 2023December 31, 2022RMS Revenue$829,377 $792,343 $739,175 Cost of revenue (excluding amortization of intangible assets)580,491 509,970 455,607 Selling, general and administrative110,982 105,965 102,795 Amortization of intangible assets23,493 21,742 20,363 Operating income$114,411 $154,666 $160,410 DSARevenue$2,451,280 $2,615,623 $2,447,316 Cost of revenue (excluding amortization of intangible assets)1,697,166 1,675,472 1,617,760 Selling, general and administrative249,097 263,770 213,870 Amortization of intangible assets62,507 70,305 82,797 Operating income$442,510 $606,076 $532,889 ManufacturingRevenue$769,332 $721,443 $789,569 Cost of revenue (excluding amortization of intangible assets)440,511 441,411 440,042 Selling, general and administrative132,803 146,311 139,027 Amortization of intangible assets52,471 45,392 43,416 Goodwill impairment215,000 — — Operating income (loss)$(71,453)$88,329 $167,084 Unallocated Corporate (1)Selling, general and administrative$258,121 $231,810 $209,408 Operating income (loss)$(258,121)$(231,810)$(209,408)(1) Operating income for unallocated corporate consists of costs associated with departments such as senior executives, corporate accounting, legal, tax, human resources, treasury, and investor relations.

77

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Fiscal YearDecember 28, 2024December 30, 2023December 31, 2022RevenueRMS$829,377 $792,343